BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van der Vries E, Collins PJ, Vachieri SG, Xiong X, Liu J, Walker PA, Haire LF, Hay AJ, Schutten M, Osterhaus AD, Martin SR, Boucher CA, Skehel JJ, Gamblin SJ. H1N1 2009 pandemic influenza virus: resistance of the I223R neuraminidase mutant explained by kinetic and structural analysis. PLoS Pathog 2012;8:e1002914. [PMID: 23028314 DOI: 10.1371/journal.ppat.1002914] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 5.6] [Reference Citation Analysis]
Number Citing Articles
1 Böhm R, Haselhorst T, von Itzstein M. Influenza Virus, Overview: Structures, Infection Mechanisms and Antivirals. In: Taniguchi N, Endo T, Hart GW, Seeberger PH, Wong C, editors. Glycoscience: Biology and Medicine. Tokyo: Springer Japan; 2015. pp. 749-67. [DOI: 10.1007/978-4-431-54841-6_148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
2 Benton DJ, Martin SR, Wharton SA, McCauley JW. Biophysical measurement of the balance of influenza a hemagglutinin and neuraminidase activities. J Biol Chem 2015;290:6516-21. [PMID: 25586179 DOI: 10.1074/jbc.M114.622308] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
3 Lin LT, Hsu WC, Lin CC. Antiviral natural products and herbal medicines. J Tradit Complement Med 2014;4:24-35. [PMID: 24872930 DOI: 10.4103/2225-4110.124335] [Cited by in Crossref: 176] [Cited by in F6Publishing: 144] [Article Influence: 22.0] [Reference Citation Analysis]
4 Russier M, Yang G, Marinova-Petkova A, Vogel P, Kaplan BS, Webby RJ, Russell CJ. H1N1 influenza viruses varying widely in hemagglutinin stability transmit efficiently from swine to swine and to ferrets. PLoS Pathog 2017;13:e1006276. [PMID: 28282440 DOI: 10.1371/journal.ppat.1006276] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
5 Takashita E, Kiso M, Fujisaki S, Yokoyama M, Nakamura K, Shirakura M, Sato H, Odagiri T, Kawaoka Y, Tashiro M. Characterization of a large cluster of influenza A(H1N1)pdm09 viruses cross-resistant to oseltamivir and peramivir during the 2013-2014 influenza season in Japan. Antimicrob Agents Chemother 2015;59:2607-17. [PMID: 25691635 DOI: 10.1128/AAC.04836-14] [Cited by in Crossref: 53] [Cited by in F6Publishing: 28] [Article Influence: 7.6] [Reference Citation Analysis]
6 Lee Y, Youn HS, Lee JG, An JY, Park KR, Kang JY, Ryu YB, Jin MS, Park KH, Eom SH. Crystal structure of the catalytic domain of Clostridium perfringens neuraminidase in complex with a non-carbohydrate-based inhibitor, 2-(cyclohexylamino)ethanesulfonic acid. Biochem Biophys Res Commun 2017;486:470-5. [PMID: 28315686 DOI: 10.1016/j.bbrc.2017.03.064] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
7 Han N, Mu Y. Locking the 150-cavity open: in silico design and verification of influenza neuraminidase inhibitors. PLoS One 2013;8:e73344. [PMID: 24015302 DOI: 10.1371/journal.pone.0073344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
8 Honda S, Minagawa Y, Noji H, Tabata KV. Multidimensional Digital Bioassay Platform Based on an Air-Sealed Femtoliter Reactor Array Device. Anal Chem 2021;93:5494-502. [PMID: 33706506 DOI: 10.1021/acs.analchem.0c05360] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Wu Y, Gao F, Qi J, Bi Y, Fu L, Mohan S, Chen Y, Li X, Pinto BM, Vavricka CJ, Tien P, Gao GF. Resistance to Mutant Group 2 Influenza Virus Neuraminidases of an Oseltamivir-Zanamivir Hybrid Inhibitor. J Virol 2016;90:10693-700. [PMID: 27654293 DOI: 10.1128/JVI.01703-16] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
10 Resa-Infante P, Paterson D, Bonet J, Otte A, Oliva B, Fodor E, Gabriel G. Targeting Importin-α7 as a Therapeutic Approach against Pandemic Influenza Viruses. J Virol 2015;89:9010-20. [PMID: 26085167 DOI: 10.1128/JVI.00583-15] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
11 Singh A, Soliman ME. Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses. Drug Des Devel Ther 2015;9:4137-54. [PMID: 26257512 DOI: 10.2147/DDDT.S81934] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
12 Takashita E, Fujisaki S, Yokoyama M, Shirakura M, Morita H, Nakamura K, Kishida N, Kuwahara T, Sato H, Doi I, Sato Y, Takao S, Shimazu Y, Shimomura T, Ito T, Watanabe S, Odagiri T, The Influenza Virus Surveillance Group Of Japan. In Vitro Characterization of Multidrug-Resistant Influenza A(H1N1)pdm09 Viruses Carrying a Dual Neuraminidase Mutation Isolated from Immunocompromised Patients. Pathogens 2020;9:E725. [PMID: 32887429 DOI: 10.3390/pathogens9090725] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Hwang SG, Ha K, Guk K, Lee DK, Eom G, Song S, Kang T, Park H, Jung J, Lim EK. Rapid and simple detection of Tamiflu-resistant influenza virus: Development of oseltamivir derivative-based lateral flow biosensor for point-of-care (POC) diagnostics. Sci Rep 2018;8:12999. [PMID: 30158601 DOI: 10.1038/s41598-018-31311-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
14 Borisevich SS, Gureev MA, Yarovaya ОI, Zarubaev VV, Kostin GA, Porozov YB, Salakhutdinov NF. Can molecular dynamics explain decreased pathogenicity in mutant camphecene-resistant influenza virus? J Biomol Struct Dyn 2021;:1-12. [PMID: 33480324 DOI: 10.1080/07391102.2020.1871414] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Han N, Mu Y. Plasticity of 150-loop in influenza neuraminidase explored by Hamiltonian replica exchange molecular dynamics simulations. PLoS One 2013;8:e60995. [PMID: 23593372 DOI: 10.1371/journal.pone.0060995] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
16 Sahoo M, Jena L, Rath SN, Kumar S. Identification of Suitable Natural Inhibitor against Influenza A (H1N1) Neuraminidase Protein by Molecular Docking. Genomics Inform 2016;14:96-103. [PMID: 27729839 DOI: 10.5808/GI.2016.14.3.96] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
17 Woods CJ, Malaisree M, Long B, Mcintosh-smith S, Mulholland AJ. Analysis and Assay of Oseltamivir-Resistant Mutants of Influenza Neuraminidase via Direct Observation of Drug Unbinding and Rebinding in Simulation. Biochemistry 2013;52:8150-64. [DOI: 10.1021/bi400754t] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
18 Guk K, Kim H, Lee M, Choi YA, Hwang SG, Han G, Kim HN, Kim H, Park H, Yong D, Kang T, Lim EK, Jung J. Development of A4 antibody for detection of neuraminidase I223R/H275Y-associated antiviral multidrug-resistant influenza virus. Nat Commun 2020;11:3418. [PMID: 32647286 DOI: 10.1038/s41467-020-17246-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
19 Peng Q, Wang Z, Wu D, Li X, Liu X, Sun W, Liu N. Identification of single amino acid substitutions (SAAS) in neuraminidase from influenza a virus (H1N1) via mass spectrometry analysis coupled with de novo peptide sequencing. Rapid Commun Mass Spectrom 2016;30 Suppl 1:179-84. [PMID: 27539435 DOI: 10.1002/rcm.7650] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
20 Tam NM, Nguyen MT, Ngo ST. Evaluation of the absolute affinity of neuraminidase inhibitor using steered molecular dynamics simulations. J Mol Graph Model 2017;77:137-42. [PMID: 28854402 DOI: 10.1016/j.jmgm.2017.08.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
21 Singh S, Malhotra AG, Jha M, Pandey KM. Implications of protein conformations to modifying novel inhibitor Oseltamivir for 2009 H1N1 influenza A virus by simulation and docking studies. Virusdisease 2018;29:461-7. [PMID: 30539048 DOI: 10.1007/s13337-018-0480-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Kim JH, Resende R, Wennekes T, Chen HM, Bance N, Buchini S, Watts AG, Pilling P, Streltsov VA, Petric M, Liggins R, Barrett S, McKimm-Breschkin JL, Niikura M, Withers SG. Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity. Science 2013;340:71-5. [PMID: 23429702 DOI: 10.1126/science.1232552] [Cited by in Crossref: 142] [Cited by in F6Publishing: 122] [Article Influence: 15.8] [Reference Citation Analysis]
23 De Clercq E. Antivirals: Past, present and future. Biochemical Pharmacology 2013;85:727-44. [DOI: 10.1016/j.bcp.2012.12.011] [Cited by in Crossref: 74] [Cited by in F6Publishing: 65] [Article Influence: 8.2] [Reference Citation Analysis]
24 Jiang L, Liu P, Bank C, Renzette N, Prachanronarong K, Yilmaz LS, Caffrey DR, Zeldovich KB, Schiffer CA, Kowalik TF, Jensen JD, Finberg RW, Wang JP, Bolon DNA. A Balance between Inhibitor Binding and Substrate Processing Confers Influenza Drug Resistance. J Mol Biol 2016;428:538-53. [PMID: 26656922 DOI: 10.1016/j.jmb.2015.11.027] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
25 Seitz C, Casalino L, Konecny R, Huber G, Amaro RE, McCammon JA. Multiscale Simulations Examining Glycan Shield Effects on Drug Binding to Influenza Neuraminidase. Biophys J 2020;119:2275-89. [PMID: 33130120 DOI: 10.1016/j.bpj.2020.10.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
26 Sun X, Li Q, Wu Y, Wang M, Liu Y, Qi J, Vavricka CJ, Gao GF. Structure of influenza virus N7: the last piece of the neuraminidase "jigsaw" puzzle. J Virol 2014;88:9197-207. [PMID: 24899180 DOI: 10.1128/JVI.00805-14] [Cited by in Crossref: 26] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
27 Ison MG. Influenza prevention and treatment in transplant recipients and immunocompromised hosts. Influenza Other Respir Viruses 2013;7 Suppl 3:60-6. [PMID: 24215383 DOI: 10.1111/irv.12170] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
28 Comas V, Moratorio G, Soñora M, Goñi N, Pereyra S, Ifran S, Moreno P, Cristina J. Phylogenetic analysis of the neuraminidase gene of pandemic H1N1 influenza A virus circulating in the South American region. Virus Res 2015;197:1-7. [PMID: 25479596 DOI: 10.1016/j.virusres.2014.11.008] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
29 Lee Y, Ryu YB, Youn HS, Cho JK, Kim YM, Park JY, Lee WS, Park KH, Eom SH. Structural basis of sialidase in complex with geranylated flavonoids as potent natural inhibitors. Acta Crystallogr D Biol Crystallogr 2014;70:1357-65. [PMID: 24816104 DOI: 10.1107/S1399004714002971] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
30 van der Vries E, Schutten M, Fraaij P, Boucher C, Osterhaus A. Influenza virus resistance to antiviral therapy. Adv Pharmacol 2013;67:217-46. [PMID: 23886002 DOI: 10.1016/B978-0-12-405880-4.00006-8] [Cited by in Crossref: 51] [Cited by in F6Publishing: 33] [Article Influence: 6.4] [Reference Citation Analysis]
31 Gillman A, Nykvist M, Muradrasoli S, Söderström H, Wille M, Daggfeldt A, Bröjer C, Waldenström J, Olsen B, Järhult JD. Influenza A(H7N9) virus acquires resistance-related neuraminidase I222T substitution when infected mallards are exposed to low levels of oseltamivir in water. Antimicrob Agents Chemother 2015;59:5196-202. [PMID: 26077257 DOI: 10.1128/AAC.00886-15] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
32 Tan H, Wei K, Bao J, Zhou X. In silico study on multidrug resistance conferred by I223R/H275Y double mutant neuraminidase. Mol Biosyst 2013;9:2764-74. [PMID: 24056678 DOI: 10.1039/c3mb70253g] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
33 Wang H, Dou D, Östbye H, Revol R, Daniels R. Structural restrictions for influenza neuraminidase activity promote adaptation and diversification. Nat Microbiol 2019;4:2565-77. [PMID: 31451775 DOI: 10.1038/s41564-019-0537-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
34 Le K, Tran D, Nguyen A, Le L. A Screening of Neuraminidase Inhibition Activities of Isoquinolone Alkaloids in Coptis chinensis Using Molecular Docking and Pharmacophore Analysis. ACS Omega 2020;5:30315-22. [PMID: 33251466 DOI: 10.1021/acsomega.0c04847] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Hurt AC, Ison MG, Hayden FG, Hay AJ. Second isirv antiviral group conference: overview. Influenza Other Respir Viruses 2013;7 Suppl 3:1-7. [PMID: 24215376 DOI: 10.1111/irv.12207] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
36 Mandal RS, Panda S, Das S. In silico prediction of drug resistance due to S247R mutation of Influenza H1N1 neuraminidase protein. Journal of Biomolecular Structure and Dynamics 2018;36:966-80. [DOI: 10.1080/07391102.2017.1305295] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
37 Wei X, Du W, Duca M, Yu G, de Vries E, de Haan CAM, Pieters RJ. Preventing Influenza A Virus Infection by Mixed Inhibition of Neuraminidase and Hemagglutinin by Divalent Inhibitors. J Med Chem 2022. [PMID: 35549211 DOI: 10.1021/acs.jmedchem.2c00319] [Reference Citation Analysis]
38 Wu Y, Vavricka CJ, Wu Y, Li Q, Rudrawar S, Thomson RJ, von Itzstein M, Gao GF, Qi J. Atypical group 1 neuraminidase pH1N1-N1 bound to a group 1 inhibitor. Protein Cell 2015;6:771-3. [PMID: 26334400 DOI: 10.1007/s13238-015-0197-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
39 Gubareva LV, Besselaar TG, Daniels RS, Fry A, Gregory V, Huang W, Hurt AC, Jorquera PA, Lackenby A, Leang SK, Lo J, Pereyaslov D, Rebelo-de-Andrade H, Siqueira MM, Takashita E, Odagiri T, Wang D, Zhang W, Meijer A. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016. Antiviral Res 2017;146:12-20. [PMID: 28802866 DOI: 10.1016/j.antiviral.2017.08.004] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 12.2] [Reference Citation Analysis]
40 Kerry PS, Mohan S, Russell RJ, Bance N, Niikura M, Pinto BM. Structural basis for a class of nanomolar influenza A neuraminidase inhibitors. Sci Rep 2013;3:2871. [PMID: 24129600 DOI: 10.1038/srep02871] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
41 Phillips AM, Shoulders MD. The Path of Least Resistance: Mechanisms to Reduce Influenza's Sensitivity to Oseltamivir. J Mol Biol 2016;428:533-7. [PMID: 26748011 DOI: 10.1016/j.jmb.2015.12.019] [Reference Citation Analysis]
42 Zeller F, Luitz MP, Bomblies R, Zacharias M. Multiscale Simulation of Receptor-Drug Association Kinetics: Application to Neuraminidase Inhibitors. J Chem Theory Comput 2017;13:5097-105. [PMID: 28820938 DOI: 10.1021/acs.jctc.7b00631] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
43 Zhang CE, Xiong Y, Dong Q, Gao D, Zhang LL, Ma LN, Peng C, Dong XP, Yan D. Comparison of reversed-phase liquid chromatography and hydrophilic interaction chromatography for the fingerprint analysis of Radix isatidis. J Sep Sci 2014;37:1141-7. [PMID: 24595986 DOI: 10.1002/jssc.201301159] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
44 Hariyono P, Kotta JC, Adhipandito CF, Aprilianto E, Candaya EJ, Wahab HA, Hariono M. A study on catalytic and non-catalytic sites of H5N1 and H1N1 neuraminidase as the target for chalcone inhibitors. Appl Biol Chem 2021;64:69. [PMID: 34549099 DOI: 10.1186/s13765-021-00639-w] [Reference Citation Analysis]
45 Hoffmann A, Schade D, Kirchmair J, Clement B, Sauerbrei A, Schmidtke M. Platform for determining the inhibition profile of neuraminidase inhibitors in an influenza virus N1 background. J Virol Methods 2016;237:192-9. [PMID: 27659246 DOI: 10.1016/j.jviromet.2016.09.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
46 Correia V, Santos LA, Gíria M, Almeida-Santos MM, Rebelo-de-Andrade H. Influenza A(H1N1)pdm09 resistance and cross-decreased susceptibility to oseltamivir and zanamivir antiviral drugs. J Med Virol 2015;87:45-56. [PMID: 25042157 DOI: 10.1002/jmv.23986] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
47 Huang L, Cao Y, Zhou J, Qin K, Zhu W, Zhu Y, Yang L, Wang D, Wei H, Shu Y. A conformational restriction in the influenza A virus neuraminidase binding site by R152 results in a combinational effect of I222T and H274Y on oseltamivir resistance. Antimicrob Agents Chemother 2014;58:1639-45. [PMID: 24366752 DOI: 10.1128/AAC.01848-13] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
48 Wan H, Yang H, Shore DA, Garten RJ, Couzens L, Gao J, Jiang L, Carney PJ, Villanueva J, Stevens J, Eichelberger MC. Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers. Nat Commun 2015;6:6114. [PMID: 25668439 DOI: 10.1038/ncomms7114] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 7.6] [Reference Citation Analysis]
49 McKimm-Breschkin JL, Williams J, Barrett S, Jachno K, McDonald M, Mohr PG, Saito T, Tashiro M. Reduced susceptibility to all neuraminidase inhibitors of influenza H1N1 viruses with haemagglutinin mutations and mutations in non-conserved residues of the neuraminidase. J Antimicrob Chemother 2013;68:2210-21. [PMID: 23759505 DOI: 10.1093/jac/dkt205] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
50 Hulswit RJG, Lang Y, Bakkers MJG, Li W, Li Z, Schouten A, Ophorst B, van Kuppeveld FJM, Boons GJ, Bosch BJ, Huizinga EG, de Groot RJ. Human coronaviruses OC43 and HKU1 bind to 9-O-acetylated sialic acids via a conserved receptor-binding site in spike protein domain A. Proc Natl Acad Sci U S A 2019;116:2681-90. [PMID: 30679277 DOI: 10.1073/pnas.1809667116] [Cited by in Crossref: 189] [Cited by in F6Publishing: 167] [Article Influence: 63.0] [Reference Citation Analysis]
51 Hanpaibool C, Leelawiwat M, Takahashi K, Rungrotmongkol T. Source of oseltamivir resistance due to single E119D and double E119D/H274Y mutations in pdm09H1N1 influenza neuraminidase. J Comput Aided Mol Des 2020;34:27-37. [PMID: 31773463 DOI: 10.1007/s10822-019-00251-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
52 Ghafouri T, Manavizadeh N. Design and simulation of a millifluidic device for differential detection of SARS-CoV-2 and H1N1 based on triboelectricity. Bioelectrochemistry 2022;145:108096. [DOI: 10.1016/j.bioelechem.2022.108096] [Reference Citation Analysis]
53 Artyushin OI, Moiseeva AA, Zarubaev VV, Slita AV, Galochkina AV, Muryleva AA, Borisevich SS, Yarovaya OI, Salakhutdinov NF, Brel VK. Synthesis of Camphecene and Cytisine Conjugates Using Click Chemistry Methodology and Study of Their Antiviral Activity. Chem Biodivers 2019;16:e1900340. [PMID: 31647170 DOI: 10.1002/cbdv.201900340] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
54 Guan S, Xu Y, Qiao Y, Kuai Z, Qian M, Jiang X, Wang S, Zhang H, Kong W, Shan Y. A novel small molecule displays two different binding modes during inhibiting H1N1 influenza A virus neuraminidases. Journal of Structural Biology 2018;202:142-9. [DOI: 10.1016/j.jsb.2017.12.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
55 Jansen AJG, Spaan T, Low HZ, Di Iorio D, van den Brand J, Tieke M, Barendrecht A, Rohn K, van Amerongen G, Stittelaar K, Baumgärtner W, Osterhaus A, Kuiken T, Boons GJ, Huskens J, Boes M, Maas C, van der Vries E. Influenza-induced thrombocytopenia is dependent on the subtype and sialoglycan receptor and increases with virus pathogenicity. Blood Adv 2020;4:2967-78. [PMID: 32609845 DOI: 10.1182/bloodadvances.2020001640] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]